Do American patients have better access to cancer drugs?

Do U.S. patients have better access to cancer drugs? When comparing the U.S. and the European Union, the question isn’t as easy to answer as it would seem. In the attached article, the author examines this question. Read article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.